Pricing Reforms, Biosimilars and Cracking Down on Company Misconduct 2010 Themes
In the wake of the global recession, governments across the world spent 2010 working toward recovery using the pharmaceutical industry as an area to cut costs through pricing reforms, but at the same time, issued guidances that aim to bring cheaper drugs to market and took a harder line on company malfeasance.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.